PCOS Rebranded: The Shift to Polyendocrine Metabolic Ovarian Syndrome
A global coalition of medical experts, led by the Endocrine Society, has officially renamed Polycystic Ovary Syndrome (PCOS) to Polyendocrine Metabolic Ovarian Syndrome (PMOS). This shift, announced in late 2024, aims to address long-standing diagnostic confusion and better reflect the systemic nature of a condition that affects approximately 170 million women worldwide. Understanding the Diagnostic…